期刊文献+

(S)-(-)-5-对苄氧基苄基-2,4-噁唑烷二酮的合成

Synthesis of (S)-(-)-5-(p-benzyloxybenzyl)-2,4-oxazolidinedione
下载PDF
导出
摘要 L-酪氨酸经O-苄基化和重氮化反应得到关键中间体——手性3-(对苄氧基苯基)-α-羟基丙酸(4);4经酯化、氨化和环化反应合成了(S)-(-)-5-对苄氧基苄基-2,4-噁唑烷二酮,总收率10%,95.4%e.e.,其结构经1H NMR和HR-MS表征。 (S)-( - )-5-(p-benzyloxybenzyl)-2,4-oxazolidinedione in total yield of 10% with 95.4% e. e. was synthesized by a three-step reaction of esterifieation, ammoniation and cyclization from chiral 3-(p-benzyloxybenze)-α-hydroxyl acid which was prepared from L-tyrosine by O-benzylation and diazotization. The structure was confirmed by ^1H NMR and HR-MS.
出处 《合成化学》 CAS CSCD 北大核心 2009年第3期320-323,共4页 Chinese Journal of Synthetic Chemistry
基金 国家自然科学基金资助项目(30371672) 北京市自然科学基金资助项目(7042042)
关键词 噁唑烷二酮 Α-羟基酸 手性 合成 oxazolidinedione α-hydroxyl acid chiral synthesis
  • 相关文献

参考文献9

  • 1王振基,申竹芳.噻唑烷二酮类不良反应研究进展[J].中国新药杂志,2005,14(11):1364-1366. 被引量:14
  • 2Hisashi Shinkai, Syoji Onogi, Masahiro Tanaka, et al. Isoxazolidine-3,5-dione and noncyclic 1,3-dicarbonyl compounds as hypoglycemic agents [ J ]. J Med Chem, 1998,41( 11 ) : 1927 - 1933.
  • 3Momose Y, Maekawa T, Yamano T, et al. Novel 5- substituted 2,4-thiazolidinedione and 2,4-oxazolidine- dione derivatives insulin sensitizers with antidiabetic activities[J]. J Med Chem ,2002 ,45 :1518 - 1534.
  • 4Hindley R M. Oxazolidine dione derivatives[ P]. WO 9 202 520,1992.
  • 5Derek J P, Nicholas C O, Tomkinson M S, et al. Differential activity of rosiglitazone enantiomers at PPAR7 [ J]. Bioorg Med Chem Lett, 1998,8:3657 - 3658.
  • 6蔡小华,陈学勇,谢兵,杜海军.(S)-2-乙氧基-3-(4-羟基苯基)丙酸乙酯的合成[J].中国医药工业杂志,2007,38(10):689-691. 被引量:1
  • 7Barot V KG, Kothari H M, Lohray B B, et al. Process for preparing 3-aryl-2-alkoxy propanoie acid derivatives without resolution[ P]. WO 2 005 019 152,2005.
  • 8Sipipragada M R, Chepyala N K R, et al. An improved process for the preparation of new antidiabetic agents[ P]. WO 0 026 200,2000.
  • 9Potlapally R K, Siripragada M R, Kotra N M, et al. Process for the preparation 3-aryl-2-hydroxy propanoic acid derivatives[ P]. US 2 002 177 726,2002.

二级参考文献27

  • 1Ott P, Ranek L, Young MA. Pharmacokinetics of troglitazone, a PPAR-γ agonist, in patients with hepatic insufficiency[J]. Eur J Clin Pharmacol, 1998,54(7): 567 - 571.
  • 2Bonkovsky HL, Azar R, Bird S, et al. Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone[J] . Dig Dis Sci ,2002, 47(7): 1632 -1637.
  • 3May LD, Lefkowitch JH, Kram MT, et al. Mixed hepatocellularcholestatic liver injury after pioglitazone therapy [ J ]. Ann Intern Med, 2002, 136(6): 449-452.
  • 4Nesto RW, Bell D, Bonow RO, et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association [J]. Diabetes Care, 2004, 27(1):256-263.
  • 5Mori Y, Murakawa Y, Okada K, et al. Effect of troglitazone on body fat distribution in type 2 diabetic patients [ J ]. Diabetes Care,1999, 22(6) :908 - 912.
  • 6Song J, Knepper MA, Hu X, et al. Rosiglitazone activates renal sodium-and water-reabsorptive pathways and lower blood pressure in normal rats[J]. J Pharmacol Exp Ther, 2004, 308(2): 426 - 433.
  • 7Mudaliar S, Chang AR, Henry RR. Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications[J]. Endocr Pruct, 2003, 9(5): 406 - 416.
  • 8Buch HN, Baskar V, Barton DM, et al. Combination of insulin and thiazolidinedione therapy in massively obese patients with Type 2 diabetes[J]. Diabet Med, 2002,19(7): 572 - 574.
  • 9Lygate CA, Hulbert K, Monfared M, et al. The PPARgammaactivator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction [ J ]. Cardiovasc Res,2003,58(3) :632 - 637.
  • 10Tan M, Johns D, Gonzalez GG, et al. Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized,double-blind, parallel-group trial [ J ]. Clin Ther, 2004, 26 ( 5 ):680 - 693.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部